{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:33Z","timestamp":1791994593128,"version":"4.4.0"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"1","funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa_19385"],"award-info":[{"award-number":["INCa_19385"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-DGOS-INSERM- ITMO Cancer-18004"],"award-info":[{"award-number":["INCa-DGOS-INSERM- ITMO Cancer-18004"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008222","name":"Universit\u00e9 de Montpellier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-INBS-09"],"award-info":[{"award-number":["ANR-10-INBS-09"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004113","name":"Universit\u00e9 Libanaise","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021565","name":"Montpellier Universit\u00e9 d\u2019Excellence","doi-asserted-by":"publisher","award":["MUSE CAPRE"],"award-info":[{"award-number":["MUSE CAPRE"]}],"id":[{"id":"10.13039\/501100021565","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Commonly used in cancer therapy, topoisomerase II (TOP2) poisons are designed to stabilize the normally transient DNA TOP2 cleavage complexes in chromatin, leading to deleterious DNA double-strand breaks. TOP2 poisons are often associated with significant side effects, highlighting the need to identify strategies aimed at improving the efficacy of TOP2 poisons in order to lower the required dosage. In this study, we demonstrated that inhibiting histone H4-lysine 20 (H4K20) methyltransferases SUV4-20H1 and SUV4-20H2 induced synthetic lethality in combination with the TOP2 poison etoposide in prostate cancer. Remarkably, the loss of the SUV4-20H enzymes, which prevents the conversion of H4K20 monomethylation to higher methylation states, increased replication fork velocity without affecting prostate cancer cell behavior. However, these apparently innocuous epigenetic changes significantly enhanced the trapping of TOP2 complexes in chromatin and increased DNA damage in response to etoposide. Furthermore, SUV4-20H depletion and the subsequent changes in H4K20 methylation impaired the repair of TOP2-induced DNA breaks by disrupting BRCA1-mediated homologous recombination processes, ultimately leading to extensive cancer cell death and significant inhibition of prostate tumor growth in vivo. Overall, these findings demonstrate that targeting the epigenetic activity of SUV4-20H is a powerful strategy to enhance the efficacy of TOP2 poisons and may represent a therapeutic alternative in prostate cancer, in which SUV4-20H2 expression emerges as a potential marker of aggressive disease and high metastatic risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Targeting the chromatin-modifying activities of the SUV4-20H enzyme family offers a promising epigenetic strategy to enhance the potency of the topoisomerase-2 poison etoposide in prostate cancer therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-3974","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:57:56Z","timestamp":1759348676000},"page":"236-254","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate Cancer"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5748-9543","authenticated-orcid":false,"given":"Fatima","family":"Alhourani","sequence":"first","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"3Faculty of Sciences, Genomics and Surveillance Biotherapy (GSBT) Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7924-0055","authenticated-orcid":false,"given":"Marine","family":"Tauziet","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4440-4936","authenticated-orcid":false,"given":"Margaux","family":"Ayeul","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0217-6575","authenticated-orcid":false,"given":"Pierre","family":"Dambrun","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6566-8234","authenticated-orcid":false,"given":"Hiba","family":"Daher","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"3Faculty of Sciences, Genomics and Surveillance Biotherapy (GSBT) Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2858-1173","authenticated-orcid":false,"given":"Julie","family":"Patouillard","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2857-2126","authenticated-orcid":false,"given":"Benoit","family":"Miotto","sequence":"additional","affiliation":[{"name":"4Universit\u00e9 Paris Cit\u00e9, Institut Cochin, INSERM, CNRS, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8681-4341","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Gennetier","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7480-3744","authenticated-orcid":false,"given":"Simon","family":"George","sequence":"additional","affiliation":[{"name":"5MGX-Montpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-7898","authenticated-orcid":false,"given":"Xavier","family":"Mialhe","sequence":"additional","affiliation":[{"name":"5MGX-Montpellier GenomiX, University of Montpellier, CNRS, INSERM, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2952-7156","authenticated-orcid":false,"given":"Mona","family":"Dergham","sequence":"additional","affiliation":[{"name":"3Faculty of Sciences, Genomics and Surveillance Biotherapy (GSBT) Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-8182","authenticated-orcid":false,"given":"Florence M.","family":"Cammas","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"6Centre National de la Recherche Scientifique (CNRS), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1456-501X","authenticated-orcid":false,"given":"Adeline","family":"Torro","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0401-7400","authenticated-orcid":false,"given":"Diego","family":"Tosi","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-4031","authenticated-orcid":false,"given":"Celine","family":"Gongora","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"6Centre National de la Recherche Scientifique (CNRS), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5326-3005","authenticated-orcid":false,"given":"Philippe","family":"Pourquier","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-0977","authenticated-orcid":false,"given":"Cyril","family":"Ribeyre","sequence":"additional","affiliation":[{"name":"2University of Montpellier, Montpellier, France."},{"name":"7Institut of Molecular Genetics of Montpellier (IGMM), CNRS UMR 5535, Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-0494","authenticated-orcid":false,"given":"V\u00e9ronique","family":"Baldin","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"6Centre National de la Recherche Scientifique (CNRS), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3299-8595","authenticated-orcid":false,"given":"Raghida","family":"Abou Merhi","sequence":"additional","affiliation":[{"name":"3Faculty of Sciences, Genomics and Surveillance Biotherapy (GSBT) Laboratory, R. Hariri Campus, Lebanese University, Hadath, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-666X","authenticated-orcid":false,"given":"Eric","family":"Julien","sequence":"additional","affiliation":[{"name":"1Institut de Recherche en Canc\u00e9rologie de Montpellier (IRCM), INSERM U1194, Institut R\u00e9gional du Cancer (ICM), Montpellier, France."},{"name":"2University of Montpellier, Montpellier, France."},{"name":"6Centre National de la Recherche Scientifique (CNRS), Montpellier, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026010203132323200_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41580-022-00452-3","article-title":"Human topoisomerases and their roles in genome stability and organization","volume":"23","author":"Pommier","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026010203132323200_bib2","doi-asserted-by":"crossref","first-page":"eadd4920","DOI":"10.1126\/sciadv.add4920","article-title":"Untangling the roles of TOP2A and TOP2B in transcription and cancer","volume":"8","author":"Uusk\u00fcla-Reimand","year":"2022","journal-title":"Sci Adv"},{"key":"2026010203132323200_bib3","doi-asserted-by":"crossref","first-page":"102837","DOI":"10.1016\/j.dnarep.2020.102837","article-title":"Excision repair of topoisomerase DNA-protein crosslinks (TOP-DPC)","volume":"89","author":"Sun","year":"2020","journal-title":"DNA Repair (Amst)"},{"key":"2026010203132323200_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem Biol"},{"key":"2026010203132323200_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrc2608","article-title":"DNA topoisomerase II and its growing repertoire of biological functions","volume":"9","author":"Nitiss","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"2026010203132323200_bib6","first-page":"100221","article-title":"Etoposide and topoisomerase II inhibition for aggressive prostate cancer: data from a translational study","volume":"25","author":"Cattrini","year":"2020","journal-title":"Cancer Treat Res Commun"},{"key":"2026010203132323200_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/BCJ20160583","article-title":"Topoisomerases as anticancer targets","volume":"475","author":"Delgado","year":"2018","journal-title":"Biochem J"},{"key":"2026010203132323200_bib8","doi-asserted-by":"crossref","first-page":"156234","DOI":"10.1016\/j.cyto.2023.156234","article-title":"Etoposide: a rider on the cytokine storm","volume":"168","author":"Bailly","year":"2023","journal-title":"Cytokine"},{"key":"2026010203132323200_bib9","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 lysine 20 methylation: key player in epigenetic regulation of genomic integrity","volume":"41","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"2026010203132323200_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1152\/physiolgenomics.00128.2020","article-title":"Methylation of histone 4\u2019s lysine 20: a critical analysis of the state of the field","volume":"53","author":"Corvalan","year":"2021","journal-title":"Physiol Genomics"},{"key":"2026010203132323200_bib11","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.15252\/embj.201796541","article-title":"Histone H4K20 tri-methylation at late-firing origins ensures timely heterochromatin replication","volume":"36","author":"Brustel","year":"2017","journal-title":"EMBO J"},{"key":"2026010203132323200_bib12","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1101\/gad.195636.112","article-title":"The role of PR-Set7 in replication licensing depends on Suv4-20h","volume":"26","author":"Beck","year":"2012","journal-title":"Genes Dev"},{"key":"2026010203132323200_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1083\/jcb.200703081","article-title":"Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination","volume":"178","author":"Benetti","year":"2007","journal-title":"J Cell Biol"},{"key":"2026010203132323200_bib14","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1101\/gad.288969.116","article-title":"SUV4-20 activity in the preimplantation mouse embryo controls timely replication","volume":"30","author":"Eid","year":"2016","journal-title":"Genes Dev"},{"key":"2026010203132323200_bib15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.210377.112","article-title":"Suv4-20h2 mediates chromatin compaction and is important for cohesin recruitment to heterochromatin","volume":"27","author":"Hahn","year":"2013","journal-title":"Genes Dev"},{"key":"2026010203132323200_bib16","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1101\/gad.476008","article-title":"A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse","volume":"22","author":"Schotta","year":"2008","journal-title":"Genes Dev"},{"key":"2026010203132323200_bib17","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.3390\/ijms23094736","article-title":"The SUV4-20H histone methyltransferases in health and disease","volume":"23","author":"Gabellini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026010203132323200_bib18","doi-asserted-by":"crossref","first-page":"6907","DOI":"10.1038\/s41467-022-34577-y","article-title":"Replication collisions induced by de-repressed S-phase transcription are connected with malignant transformation of adult stem cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat Commun"},{"key":"2026010203132323200_bib19","doi-asserted-by":"crossref","first-page":"671838","DOI":"10.3389\/fcell.2021.671838","article-title":"Epigenetic deregulation of the histone methyltransferase KMT5B contributes to malignant transformation in glioblastoma","volume":"9","author":"L\u00f3pez","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026010203132323200_bib20","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/0008-5472.CAN-20-0821","article-title":"Loss of KMT5C promotes EGFR inhibitor resistance in NSCLC via LINC01510-mediated upregulation of MET","volume":"82","author":"Pal","year":"2022","journal-title":"Cancer Res"},{"key":"2026010203132323200_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.gastro.2022.10.036","article-title":"Loss of SUV420H2-dependent chromatin compaction drives right-sided colon cancer progression","volume":"164","author":"Boonsanay","year":"2023","journal-title":"Gastroenterology"},{"key":"2026010203132323200_bib22","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3390\/ijms25052498","article-title":"Impact of histone lysine methyltransferase SUV4-20H2 on cancer onset and progression with therapeutic potential","volume":"25","author":"Papadaki","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026010203132323200_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/HEP.0000000000000559","article-title":"Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors","volume":"80","author":"Tong","year":"2024","journal-title":"Hepatology"},{"key":"2026010203132323200_bib24","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"key":"2026010203132323200_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"2026010203132323200_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"2026010203132323200_bib27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"2026010203132323200_bib28","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1186\/s12885-018-4712-z","article-title":"Rational development of synergistic combinations of chemotherapy and molecular targeted agents for colorectal cancer treatment","volume":"18","author":"Tosi","year":"2018","journal-title":"BMC Cancer"},{"key":"2026010203132323200_bib29","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biol"},{"key":"2026010203132323200_bib30","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinforma Oxf Engl"},{"key":"2026010203132323200_bib31","first-page":"2097","article-title":"Analysis of topoisomerase I\/DNA complexes in patients administered topotecan","volume":"55","author":"Subramanian","year":"1995","journal-title":"Cancer Res"},{"key":"2026010203132323200_bib32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2490-12-5","article-title":"Alterations of global histone H4K20 methylation during prostate carcinogenesis","volume":"12","author":"Behbahani","year":"2012","journal-title":"BMC Urol"},{"key":"2026010203132323200_bib33","doi-asserted-by":"crossref","first-page":"981226","DOI":"10.3389\/fonc.2022.981226","article-title":"Histone lysine methylation patterns in prostate cancer microenvironment infiltration: integrated bioinformatic analysis and histological validation","volume":"12","author":"Quan","year":"2022","journal-title":"Front Oncol"},{"key":"2026010203132323200_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nchembio.2282","article-title":"The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity","volume":"13","author":"Bromberg","year":"2017","journal-title":"Nat Chem Biol"},{"key":"2026010203132323200_bib35","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1093\/nar\/gkab1068","article-title":"Chromatin loading of MCM hexamers is associated with di-\/tri-methylation of histone H4K20 toward S phase entry","volume":"49","author":"Hayashi-Takanaka","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2026010203132323200_bib36","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1038\/s41467-018-06066-8","article-title":"Histone H4K20 methylation mediated chromatin compaction threshold ensures genome integrity by limiting DNA replication licensing","volume":"9","author":"Shoaib","year":"2018","journal-title":"Nat Commun"},{"key":"2026010203132323200_bib37","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.18632\/oncotarget.3077","article-title":"Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer","volume":"6","author":"Kirk","year":"2015","journal-title":"Oncotarget"},{"key":"2026010203132323200_bib38","doi-asserted-by":"crossref","first-page":"e110632","DOI":"10.15252\/embj.2022110632","article-title":"Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms","volume":"41","author":"Van Ravenstein","year":"2022","journal-title":"EMBO J"},{"key":"2026010203132323200_bib39","doi-asserted-by":"crossref","first-page":"110176","DOI":"10.1016\/j.celrep.2021.110176","article-title":"Assessing kinetics and recruitment of DNA repair factors using high content screens","volume":"37","author":"Martinez-Pastor","year":"2021","journal-title":"Cell Rep"},{"key":"2026010203132323200_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00412-013-0411-3","article-title":"DNA replication and homologous recombination factors: acting together to maintain genome stability","volume":"122","author":"Aze","year":"2013","journal-title":"Chromosoma"},{"key":"2026010203132323200_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41556-019-0282-9","article-title":"H4K20me0 recognition by BRCA1\u2013BARD1 directs homologous recombination to sister chromatids","volume":"21","author":"Nakamura","year":"2019","journal-title":"Nat Cell Biol"},{"key":"2026010203132323200_bib42","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.tibs.2022.03.001","article-title":"BRCA1\/BARD1 is a nucleosome reader and writer","volume":"47","author":"Witus","year":"2022","journal-title":"Trends Biochem Sci"},{"key":"2026010203132323200_bib43","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cell.2006.10.043","article-title":"Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair","volume":"127","author":"Botuyan","year":"2006","journal-title":"Cell"},{"key":"2026010203132323200_bib44","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.celrep.2014.06.013","article-title":"Concerted activities of distinct H4K20 methyltransferases at DNA double-strand breaks regulate 53BP1 nucleation and NHEJ-directed repair","volume":"8","author":"Tuzon","year":"2014","journal-title":"Cell Rep"},{"key":"2026010203132323200_bib45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ctrv.2015.05.003","article-title":"The hallmarks of castration-resistant prostate cancers","volume":"41","author":"Katsogiannou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"2026010203132323200_bib46","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1083\/jcb.201705031","article-title":"SUV420H2 is an epigenetic regulator of epithelial\/mesenchymal states in pancreatic cancer","volume":"217","author":"Viotti","year":"2018","journal-title":"J Cell Biol"},{"key":"2026010203132323200_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3892\/ijo.2024.5633","article-title":"Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis","volume":"64","author":"Zeng","year":"2024","journal-title":"Int J Oncol"},{"key":"2026010203132323200_bib48","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","article-title":"Hallmarks of DNA replication stress","volume":"82","author":"Saxena","year":"2022","journal-title":"Mol Cell"},{"key":"2026010203132323200_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0092-8674(03)00569-5","article-title":"Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing","volume":"114","author":"Anglana","year":"2003","journal-title":"Cell"},{"key":"2026010203132323200_bib50","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1083\/jcb.201208060","article-title":"The level of origin firing inversely affects the rate of replication fork progression","volume":"201","author":"Zhong","year":"2013","journal-title":"J Cell Biol"},{"key":"2026010203132323200_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature10956","article-title":"The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome","volume":"484","author":"Kuo","year":"2012","journal-title":"Nature"},{"key":"2026010203132323200_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1877-9","article-title":"H2A.Z facilitates licensing and activation of early replication origins","volume":"577","author":"Long","year":"2020","journal-title":"Nature"},{"key":"2026010203132323200_bib53","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1074\/jbc.RA118.003740","article-title":"Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes","volume":"293","author":"Rodriguez-Acebes","year":"2018","journal-title":"J Biol Chem"},{"key":"2026010203132323200_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41586-020-2842-3","article-title":"Equilibrium between nascent and parental MCM proteins protects replicating genomes","volume":"587","author":"Sedlackova","year":"2020","journal-title":"Nature"},{"key":"2026010203132323200_bib55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.gde.2021.08.004","article-title":"Replication stress: from chromatin to immunity and beyond","volume":"71","author":"Lin","year":"2021","journal-title":"Curr Opin Genet Dev"},{"key":"2026010203132323200_bib56","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-021-25051-2","article-title":"Histone H4 lysine 20 mono-methylation directly facilitates chromatin openness and promotes transcription of housekeeping genes","volume":"12","author":"Shoaib","year":"2021","journal-title":"Nat Commun"},{"key":"2026010203132323200_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcb.20045","article-title":"Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid","volume":"92","author":"Marchion","year":"2004","journal-title":"J Cell Biochem"},{"key":"2026010203132323200_bib58","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/15384101.2025.2508114","article-title":"Cell-cycle dependent inhibition of BRCA1 signaling by the lysine methyltransferase SET8","volume":"24","author":"Perez","year":"2025","journal-title":"Cell Cycle"},{"key":"2026010203132323200_bib59","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.1158\/1078-0432.CCR-17-0413","article-title":"TOP2A and EZH2 provide early detection of an aggressive prostate cancer subgroup","volume":"23","author":"Labb\u00e9","year":"2017","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-3974\/3657173\/can-24-3974.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/1\/236\/3719016\/can-24-3974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/1\/236\/3719016\/can-24-3974.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T08:13:33Z","timestamp":1767341613000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/1\/236\/771157\/Targeting-SUV4-20H-Epigenetic-Enzymes-Enhances"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-3974","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30986370","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986382","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986385","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986361","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986364","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986352","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986373","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986355","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986343","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986379","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986376","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986346","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986367","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986358","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30986349","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8227092","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}